Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.
about
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosusIntrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagementManagement of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesThe MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.Neuropsychiatric Symptoms in LupusAdvances ofcapillary electrophoresis in clinical and forensic analysis (1999-2000).Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammationRaised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupusBehavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.Systemic Lupus Erythematous Presenting as Catatonia and its Response to Electroconvulie TherapyNeuroimmunopathology in a murine model of neuropsychiatric lupusRaised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Hepatocyte SHP-1 is a Critical Modulator of Inflammation During Endotoxemia.IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus
P2860
Q24793525-2B9E2531-7A41-4D78-963A-3DE6D54A0C1CQ24798439-6B32AE20-ECA4-4489-AE60-2EFAB8882909Q26774815-FA12CBE2-D1D6-44A3-8E8A-5551B81688B9Q30476952-E54D4D19-4BB7-41A2-B9A3-CCD0F6855059Q33628713-5B2205EC-6188-46AB-AB73-8E66A61F231AQ34459628-686462AE-A19B-4DC9-BD2B-BFD3A73C9DC1Q34514906-8D86BF49-9517-472E-98DD-5708C4D7FEB9Q35126686-95005222-9BE5-4A4F-A60E-03001B31C0ABQ35225108-D8502925-BEE1-4B4C-A363-F1A38EDED5E5Q35557372-A38D9E07-E5F0-474B-B27B-068F6403983EQ35636738-13CC0556-DD2B-496E-9863-B2A9257E5B1FQ35902490-6954ED5E-6AD7-486B-BBB9-ED834C7818B0Q36088976-F6AC4FAA-D530-46A6-98D0-543D54D9EEC8Q36364472-9BE26183-20E9-439F-AA70-F80B07886B69Q36707992-FFC7B086-6639-4A6E-8EC0-E032A56A8D5EQ36955326-9A39E4CF-D9E2-4B0C-8E38-94350DC08418Q37161550-8A9DAACA-E003-40B0-8E92-D20B579F3943Q37930475-19A97C6D-8CA7-40E7-AB5E-A5AEFF5DC1D1Q38237868-6F104C08-9E20-4307-B580-841BCBF6ECC9Q38247180-24187BB2-F1F8-4748-BB3A-23A86CF03196Q38774697-8FDBD7C7-9C9E-4C30-A001-E3835F35CB3DQ40202735-F85351AE-BE8E-441B-B99F-8669C2FDE2E7Q40804722-76C963EB-72F4-4A0D-9AE6-91E604453844Q42955594-3BE37064-1F96-430C-98EB-42B98E469B68Q47136259-DFB80D8A-3C21-4299-BBE6-73D07F23A91CQ58190179-F9118CDE-14EA-4993-B2F1-3B29A1E1D93D
P2860
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@ast
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@en
type
label
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@ast
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@en
prefLabel
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@ast
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@en
P2093
P2860
P50
P356
P1476
Increased levels of proinflamm ...... ychiatric lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1136/ARD.60.4.372
P407
P50
P577
2001-04-01T00:00:00Z